Cabaletta Bio is trading 5.17% down now at $3.10 amid broad risk-off trading tied to escalating U.S.-Iran tensions and oil prices exceeding $100 per barrel.
- The Dow, S&P 500, and Nasdaq are also lower, reinforcing a global sentiment-driven move.
- Cabaletta Bio participated in the Cantor Global Healthcare Conference on September 9, 2026, highlighting rese-cel safety and manufacturing progress.
- No clearly negative company-specific announcement was reported.